MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1
Authors:
- 6 June 2016
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (2) , 231-241
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.Keywords
This publication has 44 references indexed in Scilit:
- The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cellsCell Death & Disease, 2012
- MicroRNA control of bone formation and homeostasisNature Reviews Endocrinology, 2012
- Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiationJournal of Cellular Biochemistry, 2011
- Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in CultureCell Stem Cell, 2010
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulationBritish Journal of Cancer, 2009
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellsProceedings of the National Academy of Sciences, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Self-renewal and solid tumor stem cellsOncogene, 2004